DK0637957T3 - Use of an Omega-3 Fatty Acid Emulsion to Prepare a Drug for Parenteral Treatment of Inflammatory Diseases - Google Patents
Use of an Omega-3 Fatty Acid Emulsion to Prepare a Drug for Parenteral Treatment of Inflammatory DiseasesInfo
- Publication number
- DK0637957T3 DK0637957T3 DK93909844.8T DK93909844T DK0637957T3 DK 0637957 T3 DK0637957 T3 DK 0637957T3 DK 93909844 T DK93909844 T DK 93909844T DK 0637957 T3 DK0637957 T3 DK 0637957T3
- Authority
- DK
- Denmark
- Prior art keywords
- omega
- oils
- fatty acids
- inflammatory diseases
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
The object of the invention is the use of an emulsion containing one or more polyunsaturated, long-chained omega-3 fatty acids or their pharmaceutically acceptable esters or salts and the usual adjuvants or additives to produce a medicament to be parenterally administered for the treatment of inflammatory diseases, especially inflammatory lung diseases, inflammatory intestinal diseases and lupus erythematodes, especially mucoviscidosis and/or colitis ulcerosa. In the emulsions used in the invention, the omega-3 fatty acids, their pharmaceutically acceptable esters or salts are contained in pure form or as a component of oils like natural, prepared, semi-synthetic or synthetic oils, preferably fish oils. The preferred forms of such emulsions are those containing oils, preferably fish oils, glycerin, at least one emulsifier and water for injection purposes, in which the oils contain at least 20 wt % omega-3 fatty acids.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87524392A | 1992-04-28 | 1992-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0637957T3 true DK0637957T3 (en) | 1997-08-18 |
Family
ID=25365445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93909844.8T DK0637957T3 (en) | 1992-04-28 | 1993-04-27 | Use of an Omega-3 Fatty Acid Emulsion to Prepare a Drug for Parenteral Treatment of Inflammatory Diseases |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0637957B1 (en) |
JP (1) | JP3559039B2 (en) |
AT (1) | ATE155684T1 (en) |
DE (1) | DE59306981D1 (en) |
DK (1) | DK0637957T3 (en) |
ES (1) | ES2107663T3 (en) |
GR (1) | GR3024526T3 (en) |
WO (1) | WO1993021912A1 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0754001B1 (en) * | 1994-04-01 | 2002-01-23 | Abbott Laboratories | Nutritional product for treatment of ulcerative colitis and use thereof |
US5952314A (en) | 1994-04-01 | 1999-09-14 | Demichele; Stephen Joseph | Nutritional product for a person having ulcerative colitis |
US5780451A (en) * | 1994-04-01 | 1998-07-14 | Abbott Laboratories | Nutritional product for a person having ulcerative colitis |
EP0689835A3 (en) * | 1994-06-30 | 1996-04-17 | Ajinomoto Kk | Composition comprising a mixture of amino acids and at least one N-3 fatty acid |
US6180671B1 (en) | 1998-03-10 | 2001-01-30 | Beth Israel Deaconess Medical Center, Inc. | Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
US6140374A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
US6191154B1 (en) * | 1998-11-27 | 2001-02-20 | Case Western Reserve University | Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases |
AU2001256334A1 (en) * | 2000-05-05 | 2001-11-20 | Fresenius Kabi Deutschland Gmbh | Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs |
AU2002951913A0 (en) * | 2002-10-08 | 2002-10-24 | Chevis Agriservices & Consulting Pty. Limited | Method of treatment |
CN1166368C (en) * | 2003-02-26 | 2004-09-15 | 刘威 | Seal oil cream and its prepn process and appplication in preparing intravenous injection |
DE10361667A1 (en) * | 2003-12-30 | 2005-07-28 | Omega For Life Gmbh | Novel fat powder |
GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US8962023B2 (en) | 2004-09-28 | 2015-02-24 | Atrium Medical Corporation | UV cured gel and method of making |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
GB0425658D0 (en) | 2004-11-22 | 2004-12-22 | Stanford Rook Ltd | Immunotherapeutic agent |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
WO2008119146A2 (en) * | 2007-03-29 | 2008-10-09 | Dair, Bicudo Piai | Combi-preparation of phosphoethanolamine and omega-3-fatty acid for treating bronchial asthma and copd |
MX2010003651A (en) | 2007-10-09 | 2010-07-05 | Enzymotec Ltd | Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation. |
US8993625B2 (en) | 2009-03-11 | 2015-03-31 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle |
US8241672B2 (en) * | 2009-03-11 | 2012-08-14 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
US9034389B2 (en) | 2009-03-11 | 2015-05-19 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US20110200644A1 (en) * | 2010-02-18 | 2011-08-18 | Martek Biosciences Corporation | DHA Ester Emulsions |
WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
GB201216385D0 (en) | 2012-09-13 | 2012-10-31 | Chrysalis Pharma Ag | A pharmaceutical composition |
DE102015115877A1 (en) * | 2015-09-21 | 2017-03-23 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Prophylaxis and treatment of cystic fibrosis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4678808A (en) * | 1985-10-15 | 1987-07-07 | Baxter Travenol Laboratories, Inc. | Rapid acting intravenous emulsions of omega-3 fatty acid esters |
DE3734147C2 (en) * | 1987-10-09 | 1998-10-29 | Braun Melsungen Ag | Isotonic omega-3 fatty acid-containing fat emulsion and its use |
-
1993
- 1993-04-27 EP EP93909844A patent/EP0637957B1/en not_active Expired - Lifetime
- 1993-04-27 AT AT93909844T patent/ATE155684T1/en active
- 1993-04-27 ES ES93909844T patent/ES2107663T3/en not_active Expired - Lifetime
- 1993-04-27 DK DK93909844.8T patent/DK0637957T3/en active
- 1993-04-27 DE DE59306981T patent/DE59306981D1/en not_active Expired - Lifetime
- 1993-04-27 WO PCT/EP1993/001011 patent/WO1993021912A1/en active IP Right Grant
- 1993-04-27 JP JP51890693A patent/JP3559039B2/en not_active Expired - Lifetime
-
1997
- 1997-08-22 GR GR970402169T patent/GR3024526T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE59306981D1 (en) | 1997-08-28 |
EP0637957A1 (en) | 1995-02-15 |
GR3024526T3 (en) | 1997-11-28 |
WO1993021912A1 (en) | 1993-11-11 |
EP0637957B1 (en) | 1997-07-23 |
JPH08500332A (en) | 1996-01-16 |
ES2107663T3 (en) | 1997-12-01 |
ATE155684T1 (en) | 1997-08-15 |
JP3559039B2 (en) | 2004-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0637957T3 (en) | Use of an Omega-3 Fatty Acid Emulsion to Prepare a Drug for Parenteral Treatment of Inflammatory Diseases | |
DK0607231T3 (en) | Use of an emulsion for the manufacture of a drug for intravenous administration for the treatment of skin diseases | |
KR100657642B1 (en) | Oil comprising eicosapentaenoic acid and/or stearidonic acid | |
US5178873A (en) | Essential fatty acid treatment | |
US5198468A (en) | Essential fatty acid composition | |
US5116624A (en) | Efa compositions and therapy | |
US5888541A (en) | Fatty acid treatment | |
AU618814B2 (en) | Essential fatty acid compositions | |
DK1152755T3 (en) | Essential fatty acids for the prevention of cardiovascular cases | |
DE69328618D1 (en) | Medicines based on docosahexaenoic acid, as a platelet aggregation inhibitor and against cerebral deficiency in fatty acids, and process for its manufacture. | |
KR960010832B1 (en) | Essential fatty acid composition | |
NL990032I2 (en) | Fat emulsion, process for its preparation and use. | |
DK68080A (en) | APPLICATION OF COMPLETELY ACETYLERED MONOGLYCERIDES TO REDUCE Elevated CHOLESTERINE AND NEUTRAL FAT LEVEL IN HUMAN BLOOD | |
DE60038682D1 (en) | FAT COMPOSITION | |
US5318991A (en) | Fatty acid treatment to reduce calcium excretion | |
NL980014I2 (en) | Lipid-containing emulsion intended for parenteral or enteral administration. | |
DK0456764T3 (en) | Omega-3 fatty acid-containing fat emulsion for endotracheal administration, preparation and use thereof | |
EP0585027B1 (en) | Use of fatty acids for treating abnormal tissue calcification | |
AU608571B2 (en) | Composition and method for treatment of peptic ulcers | |
KR920021151A (en) | Use of phospholipid derivatives to prepare pharmaceutical compositions with immunosuppressive properties | |
JP7198625B2 (en) | Aqueous topical pharmaceutical composition | |
BE901206A (en) | EMULSION FOR TRANSFUSION. | |
RU2019139669A (en) | SELF-EMULSING COMPOSITION ω3 FATTY ACID | |
JPH05148140A (en) | Malaria-treating medicine |